Isoniazid Induced Pure Red Blood Cell Aplasia.
anemia
isoniazid
pure red cell aplasia
tuberculosis
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
27 Feb 2020
27 Feb 2020
Historique:
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
Pure red blood cell aplasia (PRCA) is one of the uncommon causes of anemia. Drug-induced PRCA is even more infrequent. Only a few drugs are implicated in PRCA. Isoniazid is a widely used drug for the treatment of tuberculosis all over the world. It is known to cause hepatotoxicity, but in rare instances, it can lead to PRCA. A 72-year-old Caucasian male, who was started on isoniazid after the diagnosis of latent tuberculosis, presented two months later with episodes of syncope to primary care physician's office. The initial blood work showed severe anemia. There were no signs of acute or chronic gastrointestinal blood loss, and the stool hemoccult test was negative. Iron, vitamin B12, folate, lactate dehydrogenase, bilirubin, transaminases, and erythropoietin were within normal limits. Peripheral blood smear showed normochromic and normocytic anemia. A reticulocyte count was less than 1,000 per microliter. Thymoma, human immunodeficiency virus, and parvovirus B19 were ruled out. Further work-up with bone marrow biopsy confirmed pure red blood cell aplasia. A detailed review of recently started medications revealed isoniazid as the offending drug. Isoniazid was stopped. Reticulocyte count and bone marrow recovered a few days after stopping with eventual improvement in hemoglobin level, thus confirming the diagnosis of isoniazid induced red blood cell aplasia. Isoniazid is the first-line therapy for tuberculosis. Rarely, it can cause pure red blood cell suppression and severe anemia, an untoward effect, worth remembering.
Identifiants
pubmed: 32257659
doi: 10.7759/cureus.7112
pmc: PMC7101238
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e7112Informations de copyright
Copyright © 2020, Azhar et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Rheumatol Int. 2010 Nov;30(12):1643-5
pubmed: 19705120
Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):36-7
pubmed: 25332529
J Pediatr. 1998 May;132(5):898-900
pubmed: 9602212
Respir Med. 1990 Mar;84(2):171-4
pubmed: 2115192
Emerg Infect Dis. 2007 Sep;13(9):1427-8
pubmed: 18252131
Hematol Rep. 2011 Jan 13;3(1):e2
pubmed: 22184524
Am J Med Sci. 1983 Jul-Aug;286(1):2-9
pubmed: 6869413
Aging Clin Exp Res. 2015 Aug;27(4):561-2
pubmed: 25597021
Postgrad Med J. 1987 Apr;63(738):309-10
pubmed: 3120168
Am Rev Respir Dis. 1985 Jun;131(6):947-9
pubmed: 3923885
Br J Haematol. 2000 Dec;111(4):1010-22
pubmed: 11167735